ARCHIVES

In Brief: Holland Retires As Center Director, Replaced By NCI’s Aaronson; Lab Chiefs Leaving NCI

This article is from The Cancer Letter archive.

Vol. 19 No. 37 | September 24, 1993

Download PDF Visit The Full Archive

Related Articles

BMS, Exelixis To Collaborate On Drug Development.

July 27, 2001

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002

MGMT Gene Can Determine Disease Aggressiveness

June 24, 2011

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

June 9, 2006

In Brief: Univ. of New Mexico Looked Over As Possible Comprehensive Center; Missouri Asks Delay

November 26, 1976

NCI Plans 3 Percent Across-The-Board Cut To Pool Funds For High Priorities In FY08.

September 21, 2007